Prices are trending down
Usually worst during dose increases
Recommended Retatrutide Dosing Schedule and Titration Guidance In Phase 2 trials, retatrutide was titrated from a starting dose of 0.5 mg once weekly, with incremental increases at approximately four-weekly intervals to maintenance doses of 4 mg, 8 mg, or 12 mg
Back Poti, M, Bragga, B, Qin, B (Dec 2017) 'Ultra-processed food intake and obesity: what really matters for health processing or nutrient content?', Current Obesity Reports , 6/4
For investors, Viking Therapeutics remains important not only as a pipeline company but also as a potential acquisition candidate in a market where large pharma companies want differentiated obesity exposure